DB17987ExperimentalProtein Based Therapies
Yttrium Y-90 Labetuzumab: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Cell adhesion molecule CEACAM5
- Also known as
- Yttrium y 90 labetuzumab
- Code names
- 90Y-HMN-14 · S9S0Y-HMN-14
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Yttrium Y-90 Labetuzumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account